Professor Tessa Holyoake, University of Glasgow
We have provided funding for a new senior research post, to lead a new childhood leukaemia team at the Paul O’Gorman Leukaemia Research Centre in Glasgow. The basic remit of the new team will be to carry out research into the causes, mechanisms and treatment of childhood leukaemia, with a special focus on acute myeloid leukaemia.
Amount of grant: £323,603 | Date of award: May 2011
Some of the research team talk about the importance of this funding.
Professor Tessa Holyoake, Professor of Experimental Haematology. Dr Karen Keeshan, Senior Lecturer/Group Leader.
Dr Chris Halsey, Scottish Senior Clinical Research Fellow & Honorary NHS Consultant Paediatric Haematologist.
We helped to fund the cost of building and equipping the new Paul O’Gorman Leukaemia Research Centre in Glasgow, which opened in 2008.
The new Centre forms part of Glasgow’s Institute of Cancer Sciences (ICS), providing a highly interactive research environment where basic scientists and clinical academics benefit from close interactions with the Beatson Institute of Cancer Research, the Royal Hospital for Sick Children and the Beatson West of Scotland Cancer Centre.
Read more: Paul O’Gorman Leukaemia Research Centre, Glasgow
New research into acute myeloid leukaemia
We have worked with Professor Tessa Holyoake, Director of the Paul O’Gorman Leukaemia Research Centre, to provide funding for a new senior research post, to lead a new childhood leukaemia team.
The basic remit of the new team will be to carry out research into the causes, mechanisms and treatment of childhood leukaemia, with the firm intention to translate research findings into improved patient care.
Within the childhood leukaemias, the main focus will be on acute myeloid leukaemia (AML). Whilst AML accounts for only around 15 per cent of cases of childhood leukaemia, the outlook is significantly worse than for children with more common form of leukaemia, acute lymphoblastic leukaemia (ALL). There is an urgent need for improved treatments for childhood AML.
The new research team will benefit from interactions with basic scientists and clinicians working on multiple aspects of childhood leukaemia, within the Centre and across Glasgow. This will enable best progress to be made in their research into childhood leukaemia, specifically AML.
Find out more
Professor Tessa Holyoake, Director of the Paul O’Gorman Leukaemia Research Centre at the University of Glasgow, talks about the work of the centre.
At two-and-a-half Lewis was diagnosed with AML - Lewis's mum Claire tell their story.